BE864726A - Compositions pharmaceutiques contenant de la cholestyramine - Google Patents

Compositions pharmaceutiques contenant de la cholestyramine

Info

Publication number
BE864726A
BE864726A BE6046383A BE6046383A BE864726A BE 864726 A BE864726 A BE 864726A BE 6046383 A BE6046383 A BE 6046383A BE 6046383 A BE6046383 A BE 6046383A BE 864726 A BE864726 A BE 864726A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
compositions containing
containing cholestyramine
cholestyramine
pharmaceutical
Prior art date
Application number
BE6046383A
Other languages
English (en)
Inventor
R S Todd
G R Fryers
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of BE864726A publication Critical patent/BE864726A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE6046383A 1977-03-10 1978-03-09 Compositions pharmaceutiques contenant de la cholestyramine BE864726A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB10133/77A GB1566609A (en) 1977-03-10 1977-03-10 Pharmaceutical compositions containing cholestyramine and alginic acid

Publications (1)

Publication Number Publication Date
BE864726A true BE864726A (fr) 1978-09-11

Family

ID=9962124

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6046383A BE864726A (fr) 1977-03-10 1978-03-09 Compositions pharmaceutiques contenant de la cholestyramine

Country Status (14)

Country Link
US (1) US4172120A (fr)
JP (1) JPS53113007A (fr)
AU (1) AU518596B2 (fr)
BE (1) BE864726A (fr)
CA (1) CA1087986A (fr)
CH (1) CH647949A5 (fr)
DE (1) DE2810250A1 (fr)
FR (1) FR2382893A1 (fr)
GB (1) GB1566609A (fr)
IE (1) IE46479B1 (fr)
IT (1) IT7867510A0 (fr)
NL (1) NL7802588A (fr)
NZ (1) NZ186656A (fr)
ZA (1) ZA781398B (fr)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439419A (en) * 1980-02-20 1984-03-27 The Upjohn Company Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
US4414198A (en) * 1982-04-23 1983-11-08 Joseph Michaelson Rapidly disintegrable tablet composition and method
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
AU594424B2 (en) * 1986-01-03 1990-03-08 University Of Melbourne, The Gastro-oesophageal reflux composition
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
IT1190349B (it) * 1986-06-16 1988-02-16 Prodotti Formenti Srl Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
US5167965A (en) * 1987-02-09 1992-12-01 The Dow Chemical Company Palatable cholestyramine granules, tablets and methods for preparation thereof
US4837255A (en) * 1987-03-10 1989-06-06 Ciba-Geigy Corporation Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
US5910317A (en) * 1988-01-11 1999-06-08 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
DE3808191C2 (de) * 1988-03-11 1998-08-06 Astra Chem Gmbh Colestyramin enthaltende pharmazeutische Zusammensetzung
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
CA2002492A1 (fr) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Compose pharmaceutique contenant une resine echangeuse d'ions
IL95574A (en) 1989-09-09 1994-11-11 Knoll Ag Colestyramine preparation
DE3935550A1 (de) * 1989-10-25 1991-05-02 Pharmatrans Sanaq Ag Kaubare oder lutschbare arzneiform, verfahren zu ihrer herstellung und ihre verwendung
FR2664499B1 (fr) * 1990-07-16 1994-11-04 Jacques Dubois Nouvelles formes pharmaceutiques, leur procede de preparation et leurs applications.
EP0484106A1 (fr) * 1990-11-01 1992-05-06 Merck & Co. Inc. Compositions à libération contrôlée
US5166137A (en) * 1991-03-27 1992-11-24 Nobipols Forskningsstiftelse Guluronic acid polymers and use of same for inhibition of cytokine production
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
US5422101A (en) * 1993-05-14 1995-06-06 The Procter & Gamble Company Cholesterol lowering drink mix compositions
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
CN1286468C (zh) * 1997-04-30 2006-11-29 雷克特本克斯尔保健(英国)有限公司 含藻酸或藻酸盐的药物组合物
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB0012094D0 (en) * 2000-05-19 2000-07-12 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
WO2007035313A2 (fr) 2005-09-15 2007-03-29 Genzyme Corporation Formulation en sachet pour des polymères amines
NZ598728A (en) * 2006-12-22 2013-09-27 Ironwood Pharmaceuticals Inc Compositions comprising bile acid sequestrants for treating esophageal disorders
US20110129433A1 (en) * 2008-06-26 2011-06-02 Ironwood Pharmaceuticals, Inc. Compositions and Methods for Treating or Preventing Gastrointestinal Disorders and GERD-Related Respiratory Disorders
AU2009298112B2 (en) * 2008-10-02 2015-11-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Administration of an adsorbent polymer for treatment of systemic inflammation
US9186409B2 (en) 2010-04-23 2015-11-17 S-Biotek Holidng Aps Solid pharmaceutical composition for neutralizing stomach acid
PL3400944T3 (pl) 2010-11-04 2020-11-16 Albireo Ab Inhibitory ibat w leczeniu chorób wątroby
PT2637646T (pt) 2010-11-08 2016-08-17 Albireo Ab Uma combinação farmacêutica que compreende um inibidor do ibat e um sequestrador de ácido biliar
US20140323412A1 (en) 2011-10-28 2014-10-30 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
SG10201909122QA (en) 2011-10-28 2019-11-28 Lumena Pharmaceuticals Inc Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
FR2994387B1 (fr) * 2012-08-13 2016-07-29 Basf Beauty Care Solutions France Sas Ingredient hydratant cosmetique ou pharmaceutique
CA2907214A1 (fr) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Inhibiteurs de recyclage d'acide biliaire pour le traitement de l'ƒsophage de barrett et du reflux gastroƒsophagien pathologique
CA2907230A1 (fr) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Inhibiteurs du recyclage de l'acide biliaire pour le traitement de l'angiocholite sclerosante primaire et de la maladie inflammatoire de l'intestin
US20160129025A1 (en) * 2013-07-15 2016-05-12 Chengzhi Life Science., Ltd. Anti-fatigue composition and use thereof
KR102560954B1 (ko) 2014-06-25 2023-07-31 이에이 파마 가부시키가이샤 고형 제제 및 그의 착색 방지 또는 착색 감소 방법
EP3012252A1 (fr) 2014-10-24 2016-04-27 Ferring BV Formes crystallines d'Elobixibat
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
EP3413875B1 (fr) * 2016-02-09 2020-01-29 Albireo AB Pastilles de cholestyramine et procédés de préparation associés
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
CN111032019B (zh) 2017-08-09 2022-07-05 阿尔比里奥公司 考来烯胺颗粒、口服考来烯胺制剂及其用途
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
EP3810084A1 (fr) 2018-06-20 2021-04-28 Albireo AB Formulation pharmaceutique à base d'odévixibat
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
JP7562546B2 (ja) 2019-02-12 2024-10-07 ミルム ファーマシューティカルズ インコーポレイテッド 胆汁うっ滞性肝疾患を有する小児対象の成長を増加させる方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK106457C (da) 1962-01-23 1967-02-06 Ernst Helmer Hagstam Røntgenkontrastmiddel med lille massefylde og fremgangsmåde til dets fremstilling.
DE1195213B (de) * 1963-06-12 1965-06-16 Dynamit Nobel Ag Zuendladung fuer zuendunwillige Sprengstoffe
US3499960A (en) * 1965-01-25 1970-03-10 Merck & Co Inc Palatable coated particles of an anion exchange resin
US3769399A (en) * 1971-03-05 1973-10-30 L Hagerman Intestinal bile acid binding process and compositions
US3974272A (en) * 1972-09-01 1976-08-10 Merck & Co., Inc. Palatable cholestyramine coacervate compositions
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions

Also Published As

Publication number Publication date
NZ186656A (en) 1979-06-19
US4172120A (en) 1979-10-23
CH647949A5 (de) 1985-02-28
FR2382893B1 (fr) 1981-07-10
AU518596B2 (en) 1981-10-08
GB1566609A (en) 1980-05-08
FR2382893A1 (fr) 1978-10-06
JPS53113007A (en) 1978-10-03
CA1087986A (fr) 1980-10-21
AU3396978A (en) 1979-09-13
IE780486L (en) 1978-09-10
IT7867510A0 (it) 1978-03-09
ZA781398B (en) 1979-02-28
DE2810250A1 (de) 1978-09-14
IE46479B1 (en) 1983-06-29
NL7802588A (nl) 1978-09-12

Similar Documents

Publication Publication Date Title
BE864726A (fr) Compositions pharmaceutiques contenant de la cholestyramine
SE7810591L (sv) Farmaceutiska kompositioner
BE872319A (fr) Composition pharmaceutique
BE873973A (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
BE866568A (fr) Compositions therapeutiques contenant des derives de d,1-carnitine et leur utilisation
BE851590A (fr) Compositions pharmaceutiques renfermant des pyrethrinoides
FR2430410B1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
FR2347365A1 (fr) Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant
BE864359A (fr) Compositions pharmaceutiques antioestrogenes
IT1095377B (it) Composizione farmaceutica
ATA53978A (de) Insektizides mittel
IT1193847B (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline
BE826935A (fr) Compositions pharmaceutiques antivirales
ATA9378A (de) Insektizides mittel
NZ180193A (en) Antiviral compositions pharmaceutical or disinfectant
IT1111453B (it) Composizione germicida
IT7849938A0 (it) Composizioni farmaceutiche
FR2460136B1 (fr) Compositions pharmaceutiques contenant des extraits de lierre grimpant
SE7806441L (sv) Lekemedelskomposition
BE870265A (fr) Compositions pharmaceutiques anti-inflammatoires
DK461579A (da) Farmeceutisk komposition indeholdende en aryltrifluorethanol
NL7801464A (nl) Farmaceutische samenstellingen.
FR2310132A1 (fr) 14b-hydroxy-3-desoxycardenolides et analogues de ceux-ci, leur preparation et compositions pharmaceutiques les contenant
SE7602128L (sv) Legerinskompositioner
FI781507A7 (fi) Farmaceutiska kompositioner

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: RECKITT & COLMAN PRODUCTS LTD

Effective date: 19850309